The Economic Standard: IPI Model Will Cause Shortage of Life-Saving Drugs

Access to life-saving treatments makes a tremendous difference in the lives of Medicare patients. We cannot expect to copy the price models of other nations without inheriting the grueling flaws that come with these price controls. Hopefully, for the sake of consumers, President Biden’s administration will reverse Trump on this.

The entire piece is available in The Economic Standard.

FacebooktwitterredditlinkedinFacebooktwitterredditlinkedin